PROCEPT BioRobotics (PRCT) Operating Leases (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Operating Leases data on file, last reported at $24.0 million in Q1 2026.

• On a quarterly basis, Operating Leases fell 8.95% year-over-year to $24.0 million in Q1 2026; TTM through Mar 2026 was $24.0 million, a 8.95% decrease from a year earlier, with the FY2025 full-year figure at $24.7 million, down 8.24% from the prior year.
• Operating Leases for Q1 2026 stood at $24.0 million, down from $24.7 million in the prior quarter.
• Over the last five years, Operating Leases for PRCT reached as high as $49.2 million in Q3 2023 and fell as low as $3.1 million in Q2 2022.
• Historically, Operating Leases has averaged $25.0 million across 5 years, with a median of $26.2 million in 2023.
• Across the five-year window, Operating Leases tumbled 53.86% in 2022 and surged 855.26% in 2023, its largest moves.
• Year by year, Operating Leases stood at $22.7 million in 2022, then advanced by 15.34% to $26.2 million in 2023, then rose by 2.62% to $26.9 million in 2024, then declined by 8.24% to $24.7 million in 2025, then fell by 2.76% to $24.0 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $24.0 million in Q1 2026, $24.7 million in Q4 2025, and $25.2 million in Q3 2025.